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Abstract 
Wounds close by keratinocytes migrating from the edge of the wound and re-epithelializing 
the epidermis. It has been proposed that the major stimuli for wound closure are blood-
derived growth factors, chemokines, and cytokines. The small GTPase R-Ras, a known 
integrin activator, also regulates vascular permeability during angiogenesis, and blood vessels 
lacking R-Ras leak plasma proteins constantly. We explored whether the access to blood-
derived proteins influences skin wound healing in R-Ras knockout (KO) mice. In skin 
wounds, R-Ras expression was mostly restricted to the vasculature in the granulation tissue. 
Angiogenic blood vessels in the R-Ras KO mice were significantly more permeable than in 
wild-type (WT) controls. Although the distances between epidermal tongues, and the 
panniculus carnosus muscles, were significantly longer in R-Ras KO than WT controls 
before the granulation tissue formation took place, there were no differences in the wound 
closure or re-epithelialization rates or granulation tissue formation. These findings were also 
corroborated in a special splint excision wound model. Our study shows that although R-Ras 
does not influence the skin wound healing itself, but the blood vessels lacking R-Ras are 
leaky and thus could facilitate the access of blood-derived proteins to the wound.  
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Background 
When skin is wounded, migration of epidermal keratinocytes at the wound edge initiates 
within hours, whereas migration of dermal fibroblasts toward the wounded area occurs 
several days later [1]. The cells of the newly wounded skin experience a dramatic micro-
environmental transition where they are exposed to blood-derived growth factors, 
chemokines, and cytokines for the first time [1]. It has been discovered that epidermal and 
dermal cells respond differently to the exposure to blood [1-3], which explains why 
keratinocyte migration takes place immediately after wounding, whereas it takes several days 
for dermal fibroblasts to be activated [1,2].  
R-Ras is a small GTPase of the Ras family of oncogenes [4-6]. Despite the close structural 
similarity to known oncogenes of the Ras family, the function of R-Ras is distinct from other 
Ras proteins [4]. Whereas all other members of the Ras family cause malignant 
transformation, R-Ras has very little or no transforming activity [4,5,7]. Furthermore, the 
opposing functions of R-Ras and other Ras members extend to cell adhesion, differentiation, 
and signaling [5,8,9]. These opposing functions suggest that the balance between R-Ras and 
other Ras members acts as a switch that controls proliferation and migration versus 
quiescence in cells [4,10]. The generation of R-Ras knockout (KO) mice revealed a key 
function for R-Ras in regulating vascular permeability during angiogenesis in such diseases 
as cancer and diabetic retinopathy [4,10-15].  
Question addressed 
As angiogenic blood vessels lacking R-Ras leak blood-derived proteins, we explored whether 
the enhanced blood vessel leakiness in R-Ras KO mice influences wound healing.  
Experimental Design 
We explored the role of R-Ras in skin wound healing using R-Ras KO mice and two different 
wound healing models. All animal experiments were performed in accordance with protocols 
approved by the National Animal Ethics Committee of Finland. Vascular permeability assay, 
histology, immunohistochemistry, quantitative analysis of histology, morphological 
assessment of wound closure, computational expression analysis of R-Ras, animal care and 
genotyping were performed using standard methods [14,16-21] and are described in detail in the 
Supplementary data set. 
Results 
To elucidate the potential function of R-Ras in skin wound healing, we first performed 
comprehensive analysis of RNA-Seq data using the FANTOM5 (Functional ANnoTation Of 
the Mammalian genome) consortium gene expression data [22], and retrieved the organ-
specific expression pattern from the Genotype-Tissue Expression (GTEx) database [23]. Two 
CAGE (Cap Analysis of Gene Expression) peaks were identified for RRAS. For both RRAS 
CAGE peaks, the expression was the highest in pericyte, smooth muscle, keratinocyte, 
fibroblast, and endothelial samples while being substantially lower for neutrophil, B cell, 
CD8, whole blood, macrophage, and monocyte samples, while organ-specific expression 
pattern indicates R-Ras expression being confined mainly to arteries (Suppl. Fig. S1). As the 
most comprehensive cDNA sequencing analysis yielded potential hits for RRAS gene 
expression in different cell types occupying skin wounds, we then studied the presence of R-
Ras protein by immunohistochemistry in normal skin and during different stages of wound 
healing. Strong R-Ras expression was detected in angiogenic capillaries and larger blood 
vessels in the granulation tissue when the wound healing had progressed (from day 7 on) and 
in the dermal blood vessels of normal skin (Suppl. Fig. S2A-C). Some R-Ras expression was 
observed outside of the blood vessels in the granulation tissue (Suppl. Fig. S2). Double-
stainings of R-Ras with markers for endothelial, keratinocyte, smooth muscle cell, 
myofibroblast and fibroblasts were conducted. These experiments revealed that R-Ras is 
expressed in blood vessels by endothelial cells, and smooth muscle cells (Suppl. Fig. S3A, 
D). Most epidermal keratinocytes do not express R-Ras in normal skin or in wound, but we 
could detect very few, random epidermal cells that seem to express it (Suppl. Fig. S3B). R-
Ras was also expressed by very few cells in the granulation tissue that are positive for αSMA 
and fibronectin, indicating that these cells are myofibroblasts and fibroblasts, respectively 
(Suppl. Fig. S3C, E). Strong R-Ras expression persisted in the blood vessels of the 
granulation tissue throughout the wound maturation process. 
R-Ras has been recently proposed as a master regulator of vascular permeability in 
pathological angiogenesis associated with diseases, such as cancer and diabetic retinopathy 
[4,12-14]
. To address whether it also regulates vascular permeability in physiological 
angiogenesis of the skin wound, the vascular leakage was quantified by measuring Evans 
Blue (EB) dye extravasation from circulation to wound granulation tissue. The R-Ras KO 
skin wounds had approximately a 100% increase in the EB leakage than the wild-type (WT) 
skin wounds at day 7 (P=0.002) (Fig. 1E). 
It has been proposed that the “plasma>serum>plasma” transition during wound repair 
controls wound closure and re-epithelialization [1]. Thus, we hypothesized that the lack of R-
Ras might enhance wound healing by increasing the availability of natural growth factors 
from the blood, as the blood vessels lacking R-Ras could leak blood-derived proteins 
throughout the healing process. We could not see any difference in the wound closure rate 
between the WT and R-Ras KO mice (Fig. 1) (for n-values, see Suppl. Table S1). Next, we 
analyzed wound re-epithelialization at different time points during the healing process. 
Although the gap between the hyperproliferative epidermal tongues was larger in the R-Ras 
KO than WT mice at day 2, we could not see any difference between the WT and R-Ras KO 
mice at the end of the re-epithelialization process at day 7 (Fig. 1D & Suppl. Fig. S4). We 
also determined the wound contraction by the length of the wound and the distance between 
the panniculus carnosus muscles and saw that both were significantly longer in the R-Ras 
KO than in the WT mice at day 2 (Suppl. Fig. S4). However, both of these values were 
identical in all later time points between the WT and KO mice (Suppl. Fig. S4). There was no 
difference in the size of granulation or scar tissue between the R-Ras KO and WT mice at any 
time point (Fig. 1C). 
In rodents, wound closure can occur in two different ways: wound contraction and true re-
epithelialization [17,18]. As there were significant differences in the wound healing at day 2 
(especially in the distance between panniculus carnosus muscles), but not in later time points, 
it could be assumed that R-Ras KO mice have a defect in wound contraction that is 
compensated by faster re-epithelialization. Thus, we decided to explore the relationship 
between wound contraction and re-epithelialization by employing a special skin excision 
wound model, where a round silicone splint issutured into the skin to firmly attach the 
underlying dermis and subcutis, to alleviate wound closure by contraction [16-18]. No 
difference in wound closure (i.e. wound size) was found under these special conditions 
between WT and R-Ras KO mice (Fig. 2A, B). Neither could we detect any differences 
between WT and R-Ras KO mice in re-epithelialization (both the gap remaining without 
epidermis and the length of epidermal tongues were identical) or in the size of granulation 
tissue (Fig. 2C, D, E, F). 
Conclusions 
Skin wound closure is achieved by re-epithelialization and is thought to be stimulated by 
stromal cells exposed to blood-derived growth factors after the wounding caused rupture of 
blood vessels and subsequent bleeding to the injured area [1,2]. We show here that the small 
GTPase R-Ras controls vascular permeability during skin wound healing, thus wounds 
lacking R-Ras would be constantly supplied by blood-derived proteins. Although wound re-
epithelialization was delayed in R-Ras KO at day 2, we show no difference in all other time 
points during wound healing process between WT and R-Ras KO mice, indicating that R-Ras 
does not play a significant role in skin wound healing. Despite employing both excision and 
splint wound models, one needs to acknowledge that rodent wound models do not perfectly 
recapitulate human wound healing [24,25]. Thus, certain limitations are warranted for the 
interpretation of our results.  
Recently, it was demonstrated that R-Ras could be important for skin as it was required for 
tumor development in an experimental skin cancer model driven by inflammation [7]. 
However, R-Ras did not contribute directly to the transformation of epidermal cells to tumor 
cells as it was never expressed by these cells [7]. Instead, it promoted tumor progression by 
being required for both the induction of pro-inflammatory cytokine production and 
extravasation of inflammatory cells to the skin despite being expressed only in the blood 
vessels in the skin [7]. Although cytokines and inflammatory cells possess crucial roles in 
tissue regeneration and wound repair, we could not identify any role for R-Ras in skin wound 
healing. 
Prior to this study, we postulated that the vascular hyperpermeability in R-Ras KO mice 
would provide constant exposure of blood-derived growth factors to wounds to influence the 
healing process. We tried to quantify by ELISA some of the growth factors implicated in the 
blood-derived stimuli of wound closure [1-3], but could not detect them from wound lysates, 
which is in line with the short half-life of growth factors in the protease-rich milieu of the 
wound[26]. Then we tried a proteomics-based approach [27], but no growth factors were among 
the detected proteins. This finding is in line with the fact that a 30 kDa dialysis cutoff value 
was used in the processing of tissue samples for proteomics [27]. Most recent data have shown 
that R-Ras is also crucial for lumenization of new capillaries and microvessels in ischemic 
conditions [28]. Most of the angiogenic blood vessels develop without lumen in ischemic 
skeletal muscle in R-Ras KO mice and the capillaries do not provide oxygen and nutrients for 
tissue regeneration [28]. Thus, the phenotype of R-Ras KO vasculature in angiogenesis, 
hyperpermeability, but lack of lumenization of capillaries [28], could mean that the potential 
gain obtained by having blood-derived growth factors available is offset by the reduced 
supply of oxygen and nutrients.  
Despite controlling the vascular permeability of the angiogenic blood vessels in skin wounds, 
thus controlling the exposure of blood-derived proteins to the wound bed, and showing a 
difference in wound re-epithelialization at day 2, R-Ras did not influence skin wound healing 
in mice. 
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Legends for Figures 
Figure 1. R-Ras does not influence wound closure or re-epithelialization in skin wound 
healing, but R-Ras deficiency increases vascular permeability in skin wounds. WT and 
R-Ras KO mice were subjected to full thickness skin excision wounds. The wounds were 
photographed daily by a digital camera. Skin samples were collected from mice sacrificed at 
various time points. The skin samples were processed for histological evaluation. (A) The 
wound closure was assessed from digital photos using the ImageJ program and expressed as 
percentage of a day 0 wound size. (B) Representative digital pictures of the wounds from R-
Ras WT and KO mice at various time points are shown for wound closure. Scale bar 
represents 5 mm. (C) The area of granulation tissue was quantified by examining two 
microscopic sections from each wound and the results are expressed as mm2. (D) The gap 
between epidermal tongues was quantified by examining two microscopic sections from each 
wound. **, P=0.0005; Student's t-test. The results are expressed as mean ± SEM for the A 
panel and mean ± SD for the rest. (E) At day 7 of healing, Evans Blue (EB) dye was injected 
intravenously, and skin wounds and blood samples were harvested after 24 h. EB 
concentrations were measured spectrophotometrically at 620 nm, and EB concentration for 
each sample was calculated from a standard curve. Results are expressed relative to EB 
concentration in the plasma. Statistical analysis shows a significant increase in vascular 
leakage in R-Ras KO skin wounds compared to WT wounds at the 2-hour time point (**, 
P=0.002, Welch's t-test). The results are shown as mean ± SD. For n-numbers see Suppl. 
Table S1. (F) Representative wound images of days 2, 7 and 14 are shown from both R-Ras 
WT and KO mice. Scale bars: 0.5 mm (low) and 0.2 mm (high magnification). Yellow lines 
indicate granulation tissue. Low magnification images are constructed from four (day 2) or 
three (days 7 and 14) separate images covering the whole wound. 
Figure 2. R-Ras does not have an effect on wound closure process in the splint excision 
wound model. WT and R-Ras KO mice were subjected to splint skin excision wounds. The 
wounds were photographed by a digital camera and skin wound samples were collected from 
mice at day 7 and 14. The samples were processed for histological evaluation as described in 
methods. (A) The wound closure was assessed from digital photos using the ImageJ program 
and expressed as percentage of a day 0 wound size. (B) Representative digital pictures of the 
wounds from R-Ras WT and KO mice. Scale bar: 5 mm. (C) The area of granulation tissue 
was quantified by examining two microscopic sections from each wound and the results are 
expressed as mm2. (D) The gap between epidermal tongues and (E) wound length were 
quantified. The results are expressed as mean ± SD. For n-numbers in the experiments, see 
Suppl. Table S1. (F) Representative images of days 7 and 14 wounds with silicone splints are 
shown from both R-Ras WT and KO mice. Scale bars: 1 mm (low) and 0.2 mm (high 
magnification). Yellow lines indicate newly formed epidermis. 


